Table 1 Patient characteristics.
From: Effect of multidrug therapy on the prognosis of Mycobacterium avium complex pulmonary disease
Characteristic | Multidrug therapy group (n = 90) | Observation group (n = 108) | P |
|---|---|---|---|
Age, years | 62 (56–69) | 69 (62–75) | < 0.001 |
BMI, kg/m2 | 19.4 (17.2–21.2) | 18.7 (17.7–20.6) | 0.79 |
WBCs, /μL | 5765 (4803–6935) | 5715 (4610–7540) | 0.82 |
Lymphocytes, /μL | 1570 (1200–2000) | 1425 (1000–1900) | 0.30 |
CRP, mg/dL | 0.11 (0.03–0.46) | 0.10 (0.05–0.48) | 0.61 |
ESR, mm/H | 18.5 (10–38.8) | 18.5 (10–31) | 0.52 |
TP, g/dL | 7.5 (7.1–7.9) | 7.3 (6.9–7.6) (n = 102) | < 0.01 |
Albumin, g/dL | 4.1 (3.9–4.4) (n = 88) | 4.0 (3.8–4.3) (n = 101) | 0.38 |
Mycobacterial species | > 0.99 | ||
M. avium | 72 (80.0) | 87 (80.6) | |
M. intracellulare | 13 (14.4) | 15 (13.9) | |
M. avium + M. intracellulare | 5 (5.6) | 6 (5.6) | |
Diagnostic specimen | 0.73 | ||
Sputum | 44 (48.9) | 49 (45.5) | |
Bronchial lavage fluid | 46 (51.1) | 59 (54.6) | |
Acid-fast bacillus smear positivity of sputum | 22(24.4) | 23 (23.1) | 0.61 |
Time from diagnosis to treatment, months | 16 (2–68) | ||
Follow-up duration, person-years | 824.3 | 784.8 | |
BACES score | 1 (1–2.75) | 2 (1–3) | < 0.01 |
BMI < 18.5 kg/m2 | 35 (38.9) | 48 (44.4) | 0.52 |
Age ≥ 65 years | 35 (38.9) | 69 (63.9) | < 0.001 |
Cavity on chest image | 18 (20.0) | 23 (21.3) | 0.96 |
Elevated ESR | 44 (48.9) | 52 (48.1) | > 0.99 |
Sex | < 0.01 | ||
Male | 13 (14.4) | 35 (32.4) | |
Female | 77 (85.6) | 73 (67.6) | |
